Pingyao introduces anticancer drug production project

The government of Pingyao county in North China's Shanxi province meets with representatives of Beijing ATAP Bio-pharm Technology Co in Beijing on March 7. [Photo/Pingyao Rong Mei] 

The government of Pingyao county in North China's Shanxi province met with representatives of Beijing ATAP Bio-pharm Technology Co in Beijing on March 7.

The two sides reached a consensus on the investment and construction of ATAP's anticancer drug project in the county. 

Wei Jiangfeng, a top official of Pingyao, claimed that Pingyao would improve infrastructure construction, provide optimal policies for enterprise development and optimal services for project construction, and fully guarantee the development of the project. 

The anticancer drug project of ATAP is aimed mainly at developing and producing a new peptide-targeted biological broad-spectrum anticancer drug. It has already completed the preclinical animal test stage and officially started human clinical trials.

It has received about 1.5 billion yuan ($236.35 million) in investment and is expected to benefit cancer patients and improve general health and safety.